BioMarin Pharmaceutical Inc. logo BMRN - BioMarin Pharmaceutical Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 28
HOLD 13
SELL 0
STRONG
SELL 0
| PRICE TARGET: $89.93 DETAILS
HIGH: $120.00
LOW: $50.00
MEDIAN: $95.00
CONSENSUS: $89.93
UPSIDE: 66.26%

Profitability Ratios

Ratio Value
GP Margin 77.1%
EBIT Margin 15.3%
EBITDA Margin 17.8%
Operating Margin 16.6%
Pretax Margin 15.0%
Cont. Ops Margin 10.8%
Net Margin 10.8%
Bottom Line Margin 10.8%

Liquidity Ratios

Ratio Value
Current Ratio 5.21
Quick Ratio 3.50
Solvency Ratio 0.284
Cash Ratio 1.73

Valuation Ratios

Ratio Value
Price/Earnings
32.67
Hist. avg: 56.4
Peers avg: 46.4
PEG Ratio -1.71
Forward PEG -1.71
Price/Book 1.87
Price/Sales 3.54
Price/FCF 15.72
Price/Op Cash Flow 13.77

Debt Ratios

Ratio Value
Debt/Assets 0.0847
Debt/Equity 0.1056
Debt/Capital 0.0955
Long-Term Debt/Capital 0.0893
Financial Leverage 1.25

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.11
Operating Cash Flow Ratio 1.091
Operating Cash Flow/Sales 25.7%
Free Cash Flow/Operating Cash Flow 87.6%

Coverage Ratios

Ratio Value
Debt Service Coverage 22.43
Interest Coverage 48.9474
Short-Term Operating Cash Flow Coverage 95.34
Operating Cash Flow Coverage 1.29
Capital Expenditure Coverage 8.04
Dividend + Capital Expenditure Coverage 8.04

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 16.80
EPS 1.819
Debt/Share 3.4088
Cash/Share 8.14
Book Value/Share 31.74
Tangible BV/Share 29.60
Equity/Share 31.74
Operating Cash Flow/Share 4.317
Capital Expenditure/Share 0.537
FCF/Share 3.780

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.723
Earnings Before Tax/EBIT 0.904
Price/Fair Value 1.87
Debt/Market Cap 0.0532
Effective Tax Rate 27.7%
Enterprise Value Multiple 18.73